Iqvia Holdings Inc Stock Nyse
Equities
US74876Y1010
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 15.53B | Sales 2025 * | 16.66B | Capitalization | 43.43B |
---|---|---|---|---|---|
Net income 2024 * | 1.33B | Net income 2025 * | 1.58B | EV / Sales 2024 * | 3.57 x |
Net Debt 2024 * | 12.06B | Net Debt 2025 * | 11.62B | EV / Sales 2025 * | 3.3 x |
P/E ratio 2024 * |
32.7
x | P/E ratio 2025 * |
27.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 69.76% |
Latest transcript on Iqvia Holdings Inc
Managers | Title | Age | Since |
---|---|---|---|
Ari Bousbib
CEO | Chief Executive Officer | 63 | 16-10-02 |
Ronald Bruehlman
DFI | Director of Finance/CFO | 63 | 20-07-31 |
James Berkshire
COO | Chief Operating Officer | 51 | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Danhakl
BRD | Director/Board Member | 67 | 16-10-02 |
Colleen Goggins
BRD | Director/Board Member | 68 | 17-07-26 |
Ari Bousbib
CEO | Chief Executive Officer | 63 | 16-10-02 |
1st Jan change | Capi. | |
---|---|---|
+48.83% | 41.69B | |
+8.49% | 41.31B | |
-10.82% | 27.14B | |
+8.26% | 25.28B | |
-23.69% | 18.47B | |
+1.58% | 12.33B | |
+32.83% | 12.59B | |
+6.63% | 11.03B | |
-17.46% | 10.01B |